DMAA

10.20

0.05% -0.005

Handel nachbörslich: 10.20 0.005 +0.05%

Drugs Made In America Acquisition Corp (DMAA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$10.20

Offen:

$10.18

24-Stunden-Volumen:

42,187

Relative Volume:

0.47

Marktkapitalisierung:

$341.54M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

+0.05%

1M Leistung:

+0.64%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$10.18

$10.20

1-Wochen-Bereich:

$10.17

$10.20

52-Wochen-Spanne:

$9.96

$10.27

Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile

Firmenname

Drugs Made In America Acquisition Corp

Sektor

Financial (5163)

Branche

Shell Companies (154)

Telefon

954-870-3104

Adresse

2 PELICAN DR., FORT LAUDERDALE

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

DMAA's Discussions on Twitter

Vergleichen Sie DMAA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DMAA Drugs Made In America Acquisition Corp	10.20	341.54M	0	0	0	0.00
LION Lionsgate Studios Corp	5.76	1.91B	2.82B	-191.60M	-407.10M	-0.6794
AACT Ares Acquisition Corporation Ii	11.31	702.73M	0	16.92M	-1.35M	0.29
CCCM Columbus Circle Capital Corp I	10.52	480.62M	0	0	0	0.00
EQV Eqv Ventures Acquisition Corp	10.53	468.90M	0	0	0	0.00
ANSC Agriculture Natural Solutions Acquisition Corp	10.83	465.53M	0	1.30M	0	0.0301

Drugs Made In America Acquisition Corp Aktie (DMAA) Neueste Nachrichten

Jun 10, 2025

Layoff Tracker: National Resilience Closes 60% of Its Manufacturing Footprint - BioSpace

Jun 10, 2025

Jun 02, 2025

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology - TradingView

Jun 02, 2025

Jun 01, 2025

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology - Yahoo Finance

Jun 01, 2025

May 31, 2025

Trump says he is doubling tariffs on imported steel to 50% – as it happened - The Guardian

May 31, 2025

May 22, 2025

Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges - Business Wire

May 01, 2025

Apr 25, 2025

Financial Snapshot: Analyzing East West Bancorp, Inc (EWBC)’s Key Ratio Metrics - DWinneX

Apr 25, 2025

Metric Deep Dive: Understanding Drugs Made In America Acquisition Corp (DMAA) Through its Ratios - DWinneX

Apr 25, 2025

Market Resilience: Four Corners Property Trust Inc (FCPT) Finishes Weak at 27.86, Down -1.90 - DWinneX

Apr 25, 2025

Daily Progress: Coca-Cola Europacific Partners Plc (CCEP) Drop -0.78, Closing at 88.15 - DWinneX

Apr 25, 2025

Financial Analysis: Bio-Key International Inc (BKYI)’s Ratios Unveil Key Insights - DWinneX

Apr 25, 2025

Ratio Revelations: Amerant Bancorp Inc (AMTB)’s Financial Metrics in the Spotlight - DWinneX

Apr 25, 2025

Closing Strong: Lulus Fashion Lounge Holdings Inc (LVLU) Ends at 0.41, Down -7.73 from Last Close - DWinneX

Apr 25, 2025

Apr 23, 2025

What's Next for Pfizer After the Company Pulls Its Weight Loss Drug? - Yahoo Finance

Apr 23, 2025

Apr 21, 2025

The top 20 pharma companies by 2024 revenue - Fierce Pharma

Apr 21, 2025

Apr 20, 2025

AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica

Apr 20, 2025

Apr 17, 2025

WEBTOON Entertainment Inc. (NASDAQ:WBTN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Apr 17, 2025

Apr 16, 2025

ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Q1 2025 SPAC Market Update & Outlook - Business Wire

Apr 16, 2025

Apr 11, 2025

Theratechnologies’ stock soars on disclosure of acquisition offer by U.S. company - Montreal Gazette

Apr 11, 2025

Pharma’s US manufacturing moment: Where companies are making the biggest moves - Pharma Voice

Apr 11, 2025

Apr 04, 2025

10 Best Health Care Stocks to Buy for 2025 - US News Money

Apr 04, 2025

Apr 02, 2025

After saying overseas drugmakers would have a “big tax to pay,” Trump spares pharmaceuticals from reciprocal tariffs - Sherwood News

Apr 02, 2025

Apr 01, 2025

'I bought their dream': How a US company's huge land deal in Senegal went bust - Yahoo

Apr 01, 2025

Mar 31, 2025